(Q52668760)

English

Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study.

scientific article published on 7 March 2018

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study. (English)

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Sham Mailankody

5

object named as

Sham Mailankody

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

author name string

Jeffrey Wagner

1

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

John Marquart

2

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Julia Ruby

3

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Austin Lammers

4

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Victoria Kaestner

6

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Vinay Prasad

7

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

language of work or name

0 references

publication date

7 March 2018

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

360

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

k668

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

The high price of anticancer drugs: origins, implications, barriers, solutions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

A decade of reversal: an analysis of 146 contradicted medical practices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Systematic review: reliability of compendia methods for off-label oncology indications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

22 May 2018

Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

13 August 2018

Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

13 August 2018

Compendia and anticancer therapy under Medicare.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

13 August 2018

The major role of clinicians in the discovery of off-label drug therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5838851

13 August 2018

Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/29514787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent Developments in Medicare Coverage of Off-Label Cancer Therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29514787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologics debate heats up between FDA, NCCN

1 reference

https://pubmed.ncbi.nlm.nih.gov/29514787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Closed Financial Loops: When They Happen in Government, They're Called Corruption; in Medicine, They're Just a Footnote

1 reference

https://pubmed.ncbi.nlm.nih.gov/29514787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.K668

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 May 2018

http://europepmc.org/abstract/PMC/5838851

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52668760&oldid=1701054424"